Petros Pharmaceuticals, Inc. (PTPI) › Cash & EquivalentsPetros Pharmaceuticals, Inc. (PTPI) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $17.14M2021-12-31: $23.85M2022-12-31: $9.43M2023-12-31: $13.34M2024-12-31: $1.72M2025-12-31: $5.14M$5.14M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$5.14M+198.9%2026-04-15Balance as of period end2024-12-31$1.72M-87.1%2026-04-15Balance as of period end2023-12-31$13.34M+41.5%2025-03-31Balance as of period end2022-12-31$9.43M-60.5%2023-03-31Balance as of period end2021-12-31$23.85M+39.1%2023-03-31Balance as of period end2020-12-31$17.14M—2022-03-31Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)